New immunisation reference page: Live-attenuated vaccines in patients receiving regular red blood cell transfusions
Patients receiving regular red blood cell transfusions to treat chronic medical conditions such as transfusion dependent thalassaemia, sickle cell disease, inherited chronic haemolytic anaemias, or inherited bone marrow failure syndromes are often left unprotected from vaccine preventable diseases due to not meeting the required intervals between red blood cell transfusions. Evidence in this space is limited, however specialist advice suggests that immunisation of this patient group with live-attenuated vaccines is safe and recommended. As such, MVEC has created a new reference page outlining the process of immunisation for these patients. Please refer to एमवीईसी: नियमित लाल रक्त कोशिका संक्रमण प्राप्त करने वाले मरीजों में जीवित-क्षीण टीके अधिक जानकारी के लिए।
The International Coalition of Medicines Regulatory Authorities (ICMRA) statement about confidence in vaccine safety and effectiveness
In a global effort to promote confidence in the safety of vaccines, the International Coalition of Medicines Regulatory Authorities (ICMRA) have released new documentation explaining the scientific evaluation process undertaken by vaccine candidates prior to licensing, as well as discussing the ongoing safety surveillance that continues after they have been approved for use. These documents are targeted for both health care professionals as well as consumers.
Read more here:
ICMRA statement about confidence in vaccine safety and effectiveness (for healthcare professionals)
ICMRA statement about confidence in vaccines (for the general public)
Zostavax safety advisory
The Therapeutic Goods Administration (TGA) have reiterated their advice that Zostavax should not be administered to immunocompromised individuals as it is associated with a risk of mild-serious complications. This advice follows a report of a new case of a patient who was taking hydroxychloroquine and a low dose of prednisolone who died three weeks after receiving the Zostavax vaccine. Whilst it was found that the Zostavax was administered in line with existing recommendations it is important that health professionals are aware of the potential of this kind of very rare adverse event.
Read more here:
And for more information on Zoster and to access the Zostavax GP Decision Aid refer to the एमवीईसी: ज़ोस्टर immunisation reference page.
COVID19 Road to a vaccine episode 7: Professor Norman Baylor
In episode 7 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks with Professor Norman Baylor. Professor Baylor is the former Director of the Office of Vaccines Research and Review Center at the U.S. Food and Drug Administration (FDA) and is the President and CEO of Biologics Consulting and current advisor to the WHO.
In this episode they discuss:
- The important role of regulatory authorities in the development and release of new vaccines
- Emergency Use Authorisations (EUA) and their use
- Compressed timelines in the development of SARS-CoV-2 vaccines
- Requirements of regulatory bodies in the development of vaccines
- Opportunities for collaboration/”work-sharing” between the national regulatory bodies (FDA, EMA and TGA)
- The role of regulatory bodies in vaccine safety
लिंक:
- WHO draft landscape of COVID-19 candidate vaccines
- Biologics Consulting
- FDA cautions against use of hydroxychloroquine for COVID-19
- FDA: Vaccines
- WHO: Vaccine regulation
- TGA: Vaccines overview
Download the episode at:
राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर v1.0 अब उपलब्ध है
ऑस्ट्रेलियाई सरकार के स्वास्थ्य विभाग ने राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर (एनआईसीसी) का पहला संस्करण जारी किया है। यह ऑस्ट्रेलियाई टीकाकरण हैंडबुक वेबसाइट पर उपलब्ध है और दक्षिण ऑस्ट्रेलियाई स्वास्थ्य विभाग द्वारा होस्ट किए गए टीकाकरण कैलकुलेटर की जगह लेता है।
आप यहां एनआईसीसी तक पहुंच सकते हैं:
राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर
1 जुलाई 2020 - एनआईपी में बदलाव
मेनिंगोकोकल और न्यूमोकोकल रोग के खिलाफ सुरक्षा में सुधार के लिए आज से राष्ट्रीय टीकाकरण कार्यक्रम (एनआईपी) में बदलाव किए गए हैं।
आप इन परिवर्तनों के बारे में अधिक यहाँ पढ़ सकते हैं:
आप अपडेटेड विक्टोरियन टीकाकरण कार्यक्रम यहां देख सकते हैं:
हमने इन परिवर्तनों को दर्शाने के लिए निम्नलिखित पृष्ठों को अपडेट किया है:
- एमवीईसी: एस्प्लेनिया
- एमवीईसी: आदिवासी और टोरेस स्ट्रेट आइलैंडर टीकाकरण सिफारिशें
- एमवीईसी: मेनिंगोकोकल रोग और टीके
- एमवीईसी: मेनिंगोकोकल टीके विशेष जोखिम और इम्यूनोसप्रेस्ड रोगियों में
- एमवीईसी: 20 वर्ष की आयु तक खरीद के लिए अनुशंसित अतिरिक्त टीके (अनफंडेड)
- एमवीईसी: हृदय रोग वाले बच्चे
- एमवीईसी: प्रीटरम शिशु टीकाकरण
एमवीईसी टीकाकरण संदर्भ पृष्ठ अद्यतन एनआईपी परिवर्तनों को दर्शाता है 1 जुलाई 2020
हमने 1 जुलाई 2020 तक राष्ट्रीय टीकाकरण कार्यक्रम (एनआईपी) में हुए परिवर्तनों को दर्शाने के लिए निम्नलिखित एमवीईसी टीकाकरण संदर्भ पृष्ठों को अपडेट किया है:
- एमवीईसी: आदिवासी और टोरेस स्ट्रेट आइलैंडर टीकाकरण सिफारिशें
- एमवीईसी: एस्प्लेनिया
- एमवीईसी: हृदय रोग वाले बच्चे
- एमवीईसी: मेनिंगोकोकल रोग और टीके
- एमवीईसी: मेनिंगोकोकल टीके विशेष जोखिम और इम्यूनोसप्रेस्ड रोगियों में
- एमवीईसी: प्रीटरम शिशु टीकाकरण
- एमवीईसी: 20 वर्ष की आयु तक खरीद के लिए अनुशंसित अतिरिक्त टीके (अनफंडेड)
Researchers at RCH show no association in vaccine uptake as a result of mandatory vaccination policies
Researchers from the Royal Children's Hospital in Melbourne's Specialist Immunisation Clinic and Drop in Centre have demonstrated mandatory immunisation policies 'No Jab, No Pay' and 'No Jab, No Play' show no association in vaccine uptake. Whilst the policies motivated attendance to a tertiary service, they don't appear to be changing vaccination behaviour as was the intention, with further evaluation required.
Read more here:
COVID19 Road to a vaccine episode 6: Professor Paul Offit
In episode 6 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks to Professor Paul Offit. Professor Offit is an infectious diseases physician and Director of the Children's Hospital of Philadelphia (CHoP) Vaccine Education Center (VEC). The VEC website inspired the creation of the Melbourne Vaccine Education Centre, the host of this podcast series.
In this episode they discuss:
- The impact of SARS-CoV-2 on health care workers and the importance of a vaccine
- Preventative therapies and randomised controlled trials in a pandemic, specifically the use of hydroxychloroquine for COVID-19 and the other trials involving health care workers
- COVID-19 in children - do they play a role in transmission? Will they be a target for vaccine studies?
- Paediatric Inflammatory Multisystem Syndrome (PIMS) - how can we factor this emerging condition into safety planning?
लिंक:
- New York Times: We know crowding affects the spread. It may affect the death rate.
- New York Times: Re-thinking COVID-19 in children
- Vaccine Education Center
- MVEC: Clinical trial of BCG vaccine against COVID-19
- Paul Offit: Deadly Choices
- Paul Offit: The Cutter Incident
You can listen to this episode here:
NCIRS वेबिनार - NIP परिवर्तन, जो आपको जानना आवश्यक है
1 जुलाई 2020 को राष्ट्रीय टीकाकरण कार्यक्रम (एनआईपी) में महत्वपूर्ण बदलाव और न्यूमोकोकल, मेनिंगोकोकल और हेपेटाइटिस ए टीकाकरण के लिए सिफारिशें प्रभावी होंगी।
NCIRS ने इन परिवर्तनों के बारे में एक वेबिनार की मेजबानी की जो अब ऑनलाइन देखने के लिए उपलब्ध है:
NCIRS: आगामी NIP परिवर्तन: आपको क्या जानने की आवश्यकता है